A DOUBLE-BLIND, RANDOMIZED, CONTROLLED MULTICENTRE STUDY TO ASSESS THE EFFICACY AND SAFETY OF RAMIPRIL MR CAPSULES (PANACEA BIOTEC LTD) IN COMPARISON WITH CARDACE (AVENTIS PHARMA LIMITED INDIA) IN PATIENTS OF MILD TO MODERATE HYPERTENSION.
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Ramipril (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 07 Dec 2010 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India record.
- 27 Nov 2010 New trial record